Merck, Eli Lilly Declining COVID-19 Product Sales
On Thursday, Merck & Co. forecast a sharp decline in sales of its COVID-19 antiviral drug after global demand dwindled as the pandemic abated, Reuters reported. Merck believes sales of its COVID-19 drug molnupiravir will grow from $5.68 billion in 2022 to about $1 billion in 2023. Eli Lilly & Co. is also in decline, with lower COVID-19 antibody sales and lower earnings in its most recent quarter. $7.3 billion, just below analyst estimates, up 9%, according to the company. wall street journalReasons for the decline are believed to be due to currency conversion, lower realized prices, and reduced demand for some products.
Republican AG warns pharmacies against mailing abortion pills
On Wednesday, 20 Republican state attorneys general (AG) told Walgreens Boots Alliance Inc. and CVS Health Corp that mailing the abortion drug mifepristone could violate federal and state law. Reuters reported. AG informed pharmacies that the Comstock Act, a 19th-century federal law, prohibited the use of email services to send and receive abortion pills. Walgreens and CVS are not certified to dispense drugs in legal abortion areas, but have said they hope to do so.
Depression, Anxiety, and Research Findings Related to Long-Term Pollutant Exposure
Increased incidences of depression and anxiety, even at low levels, have been reported to be associated with long-term air pollution new york timesThe findings follow other evidence that fossil fuels may be harming mental health. Measured pollutants include particulate matter, nitric oxide and nitrogen dioxide, most of which are released into the atmosphere when fossil fuels are burned. The study also considered participants’ socioeconomic status and pre-existing mental illness, highlighting adverse consequences beyond physical health hazards.
